227 related articles for article (PubMed ID: 36901700)
21. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
[TBL] [Abstract][Full Text] [Related]
23. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
Xu CY; Dong JF; Chen ZQ; Ding GS; Fu ZR
Cancer Control; 2019; 26(1):1073274819846593. PubMed ID: 31046434
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
[No Abstract] [Full Text] [Related]
25. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
[TBL] [Abstract][Full Text] [Related]
26. Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1.
Tao S; Li H; Ma X; Ma Y; He J; Gao Y; Li J
Cancer Gene Ther; 2021 Jun; 28(6):634-648. PubMed ID: 33154575
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
[TBL] [Abstract][Full Text] [Related]
28. Identification of the prognostic, diagnostic, and biological significance of the miR-148a-3p/cathepsin A axis in hepatocellular carcinoma.
Zhao X; Chai W; Wang T; Chen X; Zhang L; Li F; Liu R
J Biochem Mol Toxicol; 2022 Dec; 36(12):e23208. PubMed ID: 36065643
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.
Yang H; Fang F; Chang R; Yang L
Hepatology; 2013 Jul; 58(1):205-17. PubMed ID: 23401231
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
31. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
[TBL] [Abstract][Full Text] [Related]
32. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
[TBL] [Abstract][Full Text] [Related]
34. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
[TBL] [Abstract][Full Text] [Related]
35. Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.
Long HD; Ma YS; Yang HQ; Xue SB; Liu JB; Yu F; Lv ZW; Li JY; Xie RT; Chang ZY; Lu GX; Xie WT; Fu D; Pang LJ
Mol Biol Rep; 2018 Dec; 45(6):2615-2623. PubMed ID: 30341691
[TBL] [Abstract][Full Text] [Related]
36. CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression.
Wang H; Chen W; Jin M; Hou L; Chen X; Zhang R; Zhang J; Zhu J
Mol Cancer; 2018 Nov; 17(1):165. PubMed ID: 30470261
[TBL] [Abstract][Full Text] [Related]
37. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
[TBL] [Abstract][Full Text] [Related]
38. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
[TBL] [Abstract][Full Text] [Related]
39. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
40. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
